Latest Insider Transactions at Sonnet Bio Therapeutics Holdings, Inc. (SONN)
This section provides a real-time view of insider transactions for Sonnet Bio Therapeutics Holdings, Inc. (SONN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Sonnet BioTherapeutics Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Sonnet BioTherapeutics Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2021
|
Pankaj Mohan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
320,135
+32.19%
|
-
|
|
Dec 15
2021
|
John K. Cini Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,034
+20.83%
|
-
|
|
Dec 15
2021
|
Raghu Rao Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
14,152
+38.75%
|
-
|
|
Dec 15
2021
|
Donald J. Griffith Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+11.93%
|
-
|
|
Dec 15
2021
|
Susan Dexter Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,104
+33.27%
|
-
|
|
Jun 09
2021
|
Pankaj Mohan Chairman, President and CEO |
BUY
Open market or private purchase
|
Direct |
32,000
+4.27%
|
$32,000
$1.55 P/Share
|
|
Jun 09
2021
|
Richard T Kenney Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+23.08%
|
$15,000
$1.54 P/Share
|
|
May 25
2021
|
Susan Dexter Chief Technical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,145
-13.78%
|
$10,145
$1.51 P/Share
|
|
May 25
2021
|
Donald J. Griffith Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,235
-4.24%
|
$4,235
$1.51 P/Share
|
|
May 25
2021
|
John K. Cini Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,004
-5.88%
|
$14,004
$1.51 P/Share
|
|
May 19
2021
|
Richard T Kenney Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+22.22%
|
$10,000
$1.55 P/Share
|
|
Mar 25
2021
|
Richard T Kenney Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+50.0%
|
-
|